Brefeldin A

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameBrefeldin A

Drug Alias NameBFANSC-89671

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics

Mechanisms of ActionProtein synthesis inhibitorsBrefeldin A-inhibited guanine nucleotide-exchange protein 1 modulatorsBrefeldin A-inhibited guanine nucleotide-exchange protein 2 modulators +[4]

TargetsBrefeldin A-inhibited guanine nucleotide-exchange protein 1Brefeldin A-inhibited guanine nucleotide-exchange protein 2Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1

Therapy Area/IndicationsInflammationNeoplasmsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBraton Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBraton Biotech Inc

Active IndicationsN/A

Inactive IndicationsInflammationNeoplasmsHIV Infections

Other Information

ATC CodeN/A